Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MELBOURNE, Australia, July 13, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s novel drug SCENESSE® (afamelanotide) has been granted a Notice of Compliance (NOC) by Health Canada for the prevention of...
-
June 29, 2026 Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAPandUpdate on Serenta Progress Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “the Company”),...
-
UFCW Canada and Ecojustice are disappointed by recent Health Canada decisions to make pesticides safety information optional for employers.
-
Health Canada Priority Review targets an expedited 180-day review period for givinostat, reflecting Italfarmaco’s commitment to Canadian DMD communityNDS is based on Italfarmaco’s Phase 3 EPIDYS trial...
-
L’examen prioritaire de Santé Canada vise un délai accéléré de 180 jours pour l’examen du givinostat, reflétant l’engagement d’Italfarmaco envers la communauté canadienne touchée par la dystrophie...
-
Vitacore launches FormFit™, a custom-fit CPAP mask platform, following Health Canada Medical Device Licence Approval.
-
Health Canada authorizes North America’s first rapid Hepatitis B point-of-care test, delivering results in just 15 minutes.
-
WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve®...
-
Shawn Buckley drives The World’s Greatest Health Van to Ottawa with 150,000 petitions urging Parliament to protect access to natural health.
-
Toronto, ON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The Canadian Vaping Association urges provincial and federal health ministers to focus on youth prevention and education programs that provide a...